2Suppliers
6Customers
1Debt Items
14Related Chains

Source-Backed Evidence Depth

Fortrea Holdings Inc. (FTRE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
2Distinct source URLs
3High confidence
0.746Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Fortrea Holdings Inc. Suppliers

TickerNameConfidenceEvidence
IQV IQVIA Holdings Inc. 72% Reciprocal relationship from IQV graph: $ 2,163 November 1, 2024 – November 30, 2024 4.9 $ 206.15 4.9 $ 1,163 December 1, 2024 – December 31, 2024 0.7 $ 195.56 0.7 $ 1,013 5.6 5.6 Stock Performance G…
LH Labcorp Holdings Inc. 72% Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: …

Fortrea Holdings Inc. Customers

TickerNameConfidenceEvidence
PHARMACEUTICAL-CUSTOMER PHARMACEUTICAL-CUSTOMER 92% As of March 31, 2026, one pharmaceutical customer accounted for 18.5 % of the Company's combined gross accounts receivable and unbilled services.
LH Labcorp Holdings Inc. 72% Item 1A. “Risk Factors” of this document. 4 Table of Contents PART I ITEM 1. BUSINESS Overview Fortrea Holdings Inc. is a leading global contract research organization (“CRO”), providing biopharmaceu…
LH Labcorp Holdings Inc. 72% Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: …
ENDEAVOR-BUYER-LLC ENDEAVOR-BUYER-LLC 62% TREA HOLDINGS INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (dollars and shares in millions, except per share data) 1. BASIS OF FINANCIAL STATEMENT PRESENTATION Description of B…
ENDPOINT-CLINICAL-INC ENDPOINT-CLINICAL-INC 62% TREA HOLDINGS INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (dollars and shares in millions, except per share data) 1. BASIS OF FINANCIAL STATEMENT PRESENTATION Description of B…
FORTREA-PATIENT-ACCESS-INC FORTREA-PATIENT-ACCESS-INC 62% TREA HOLDINGS INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (dollars and shares in millions, except per share data) 1. BASIS OF FINANCIAL STATEMENT PRESENTATION Description of B…

Fortrea Holdings Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
FTRE-DEBT Debt stack $1.1B 90% Market cache reports total debt of $1.1B.

Fortrea Holdings Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Fortrea Holdings Inc..

Fortrea Holdings Inc. Ownership

HolderNameConfidenceEvidence
FTRE-OWNER-GOLDMAN-SACHS-GROUP-INC GOLDMAN SACHS GROUP INC 90% 13F overlay lists GOLDMAN SACHS GROUP INC as top holder; 332 tracked holders.

Fortrea Holdings Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EBS Emergent BioSolutions Inc. 100.00 2
SNYNF Sanofi 100.00 2
BDRX Biodexa Pharmaceuticals Plc 100.00 2
IQV IQVIA Holdings Inc. 100.00 1 ['supplier']
TMO Thermo Fisher Scientific Inc. 50.00 2
MEDP Medpace Holdings, Inc. 50.00 2
SPGI S&P Global Inc. 50.00 2
VENDOR VENDOR 50.00 2
CBIH Cannabis Bioscience International Holdings, Inc. 50.00 2
IDXG Interpace Biosciences, Inc. 50.00 2
TEM Tempus AI, Inc. 50.00 2
LH Labcorp Holdings Inc. 38.88 1 ['customer', 'supplier']
SABS SAB Biotherapeutics, Inc. 36.29 1 ['spend']
TD The Toronto-Dominion Bank 14.78 2
🔐
FTRE
Unlock FTRE Supply Chain Data
Verified relationships include:
IQVIQVIA Holdings Inc.Supplier72%
LHLabcorp Holdings Inc.Supplier72%
PHARMACEUTICAL-CUSTOMERPHARMACEUTICAL-CUSTOMERCustomer92%
LHLabcorp Holdings Inc.Customer72%
+6 more relationships locked
Subscribe — View plans →